Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets

► Growing evidence on involvement of inflammation in neurodegenerative processes. ► Pentraxin upregulation in AD brain and contribution to neurodegeneration. ► Changes of pentraxin levels in AD biological fluids related to disease progression. ► Pentraxins as therapeutic targets: anti-pentraxin antibodies, anti-inflammatory drugs.